Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1034(1-2): 40-50, 2005 Feb 09.
Article in English | MEDLINE | ID: mdl-15713258

ABSTRACT

Adenosine triphosphate is released into the synaptic cleft of the neuromuscular junction during normal synaptic transmission, and in much greater quantities following injury and ischaemia. There is much data to suggest roles for presynaptic P2 receptors but little to demonstrate which specific receptor subunits are present. Here we show P2X7 receptor subunits on presynaptic motor nerve terminals from birth, but no evidence for P2X1, P2X2, P2X3, P2X4, P2X5 or P2X6 receptor subunits. Further, P2X receptor subunits are present as multimeric, membrane-inserted receptors. A selective agonist, 2'-3'-O-(4-benzoylbenzoyl)-adenosine 5'-triphosphate (BzATP: 100 microM), triggers vesicle release from motor nerve terminals, which is blocked by P2X7RS-specific concentrations of periodate oxidised ATP (OxATP: 100 microM) and brilliant blue G (BBG: 1 microM), but not by suramin (100 microM). Vesicle release is enhanced in the absence of extracellular divalent cations and occurs through activation of the ion channel and not any associated large pore, as we failed to label nerve terminals with large membrane-impermeant molecules after addition of BzATP. We conclude that a P2X7-like receptor is present at mouse motor nerve terminals, and that their activation promotes vesicle release.


Subject(s)
Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/metabolism , Motor Neurons/metabolism , Muscle, Skeletal/innervation , Neuromuscular Junction/metabolism , Receptors, Purinergic P2/metabolism , Synaptic Transmission/physiology , Adenosine Triphosphate/pharmacology , Animals , Benzenesulfonates/pharmacology , Cations, Divalent/metabolism , Ion Channels/drug effects , Ion Channels/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Motor Neurons/drug effects , Motor Neurons/ultrastructure , Neuromuscular Junction/drug effects , Neuromuscular Junction/ultrastructure , Platelet Aggregation Inhibitors/pharmacology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Protein Subunits/metabolism , Purinergic P2 Receptor Agonists , Purinergic P2 Receptor Antagonists , Receptors, Purinergic P2X7 , Synaptic Membranes/drug effects , Synaptic Membranes/metabolism , Synaptic Membranes/ultrastructure , Synaptic Transmission/drug effects , Synaptic Vesicles/drug effects , Synaptic Vesicles/metabolism , Synaptic Vesicles/ultrastructure , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...